ANZBMS Hypophosphataemic Bone Disorders Case Series

JBMR Plus Special Edition on Hypophosphataemic Bone Disorders 

An ANZBMS initiative

Supported by an independent Medical Education Grant from Kyowa Kirin Australia

Brief: The Australia and New Zealand Bone and Mineral Society (ANZBMS) is excited to announce a call for original research and case reports on hypophosphataemic bone disorders. Hypophosphataemic bone disorders encompass a group of genetic and acquired conditions that lead to a range of musculoskeletal abnormalities and systemic complications from childhood through to adulthood. They often present a diagnostic challenge requiring a multidisciplinary approach for effective management.

This initiative by ANZBMS aims to encourage healthcare professionals, researchers, and experts in the field to provide their experience and expertise to disseminate high-quality research exploring various aspects of hypophosphataemic bone disorders (other than nutritional rickets) and its management, including but not limited to:

  1. X-linked hypophosphataemia
  2. Autosomal dominant hypophosphataemic rickets
  3. Tumour-induced osteomalacia
  4. Ferric carboxymaltose infusion induced hypophophataemia 
  5. Other rare forms of hypophosphataemic bone disorders

We aim to compile valuable clinical insights and experiences related to hypophosphataemic bone disorders, contributing to improved understanding, diagnosis and treatment strategies. Young children as well as older adults affected by these conditions may benefit from research that informs both clinicians and scientists and advances the management of hypophosphataemic disorders. Submissions by clinicians and scientists at all career stages are encouraged. ANZBMS membership is not required.

This issue will be supported by the guest editors Prof Richard Prince, Prof Craig Munns, Dr Albert Kim and Dr Madhuni Herath.

Article Selection
This is a two-stage, competitive process:

Scope: We invite the following types of articles for submission:

Format: An abstract of up to 500 words and including an

A table (x1) and/or figure (x1) can be included and will not count towards the word count, nor will the references.
Case reports must be de-identified to protect patient privacy, and written consent should be obtained from the patient.
Successful abstract authors from Stage 1 will be invited to submit a full manuscript for consideration of publication adhering to the author guidelines published at 


Email your submissions (instructions below) to by 28th January 2024 with the subject ‘Abstract Submission ANZBMS HBD initiative’.

For more information, please email: with the subject ‘ANZBMS HBD initiative’¬†

This initiative is supported by an independent Medical Education Grant from Kyowa Kirin Australia covering the publication costs for up to 10 successful manuscripts.

Download ANZBMS Hypophosphataemic Bone Disorders Case Series information sheet.